Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Cancer 8, 662 (1 September 2008) | doi:10.1038/nrc2472
Tumorigenesis: Marching to a different drum
Abstract
Fusion proteins with inappropriate tyrosine kinase activity drive the progression of several human cancers and have proved to be useful therapeutic targets. Discerning their function in tumours has therefore become a priority.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
